Key result
Transradial approach for percutaneous closure of patent ductus arteriosus with the Amplatzer duct occluder II was successfully performed in a 66-year-old female.
Why the study?
Can patent ductus arteriosus be successfully closed using the Amplatzer duct occluder II device via a transradial approach?
Case Report (n=1)
Can patent ductus arteriosus be successfully closed using the Amplatzer duct occluder II device via a transradial approach?
This case report demonstrates the feasibility of using a transradial approach for percutaneous closure of a patent ductus arteriosus with the Amplatzer duct occluder II device.
Feasibility of transradial PDA closure with ADO II shown in one adult; leaves open safety, efficacy, and generalizability.
Percutaneous patent ductus arteriosus (PDA) closure is a safe and feasible treatment, and it is recommended over surgical approach in the majority of cases. Amplatzer duct occluder (ADO-AGA Medical Corporation, Golden Valley, MN) is the preferred device for transcatheter treatment of PDA. Recently, the ADO II (AGA Medical Corporation, Golden Valley, MN), allowing PDA closure through a small delivery catheter from an antegrade or retrograde approach, received the European Community mark approval. Here, we report, for the first time, successful PDA closure in a 66-year-old female with the ADO II device, using a transradial approach.
No takes yet. Share an insight, caveat, or question.
Cassese et al. (2010) conducted a case report in Patent ductus arteriosus (n=1). Transradial approach for percutaneous closure with Amplatzer duct occluder II was evaluated on Successful PDA closure. Transradial approach for percutaneous closure of patent ductus arteriosus with the Amplatzer duct occluder II was successfully performed in a 66-year-old female.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: